Our Values
Accurate
Ridiculously accurate compared to existing methods, providing unparalleled confidence in diagnostics.
Accessible
Delivers optimal results with minimal training, designed for seamless use in
any healthcare setting.
Innovative
Redefines diagnostic standards for
preterm conditions, spanning from fetal development to neonatal care.
Every Baby Deserves
the Best Start
Envision a world where pregnancy and childbirth are universally celebrated as beautiful, blessed, and joyful experiences for mothers, babies, and their families.
Our Vision
Our mission is to protect these precious moments by preventing potential health risks and ensuring the safety and well-being of Every Mother and Every Baby.
We are committed to developing and delivering innovative, cutting-edge technologies that prioritize maternal and neonatal health, shaping a future where Every Baby receives the healthiest and happiest start in life.
OUR SOLUTION
Revolutionizing Preterm Birth Diagnostics
EveryBaby offers a revolutionary handheld diagnostic device powered by advanced Electrical Impedance Spectroscopy (EIS) technology, delivering 21% greater diagnostic accuracy than existing methods.
With its intuitive design and efficiency, EveryBaby empowers healthcare providers worldwide to enable timely interventions and improve outcomes for mothers and babies.
High-Risk Group (26–28 Weeks)
-
EveryBaby AUC: 0.80
-
Ultrasound and Fibronectin: AUC 0.66
All Women Group (20–22 Weeks)
-
EveryBaby AUC: 0.76
-
Ultrasound: AUC 0.72 / Fibronectin: AUC 0.62
Enhanced Accuracy with Preterm Birth History
-
Prediction of spontaneous preterm birth before 37 weeks: AUC 0.83
-
Prediction of spontaneous preterm birth before 32 weeks: AUC 0.86
High-Risk Group (26–28W)AUC (95%CI)SensitivitySpecificityEveryBaby80%93%67%Transviginal Ultrasound66%79%46%Fetal Fibronectin66%50%78%All Women Group (20–22 W)AUC (95%CI)SensitivitySpecificityEveryBaby76%70%80%Transviginal Ultrasound72%62%75%Fetal Fibronectin62%59%63%Source: Assessing the Risk of Spontaneous Premature Birth by Electrical Impedance Spectroscopy of the Cervix (449 participants)
We are preparing for our next commercial clinical trial in collaboration with PureHealth—coming soon!
-
Our groundbreaking research and development efforts are backed by numerous peer-reviewed studies and publications:
-
Anumba, D. O., Brown, B. H., & Jokhi, R. P. (2020). The value of cervical electrical impedance spectroscopy to predict spontaneous preterm delivery in asymptomatic women: The ECCLIPPx prospective cohort study. Ultrasound in Obstetrics & Gynecology, August 15. LINK
-
Jokhi, R. P., Ghule, V. V., Brown, B. H., & Anumba, D. O. (2009). Reproducibility and repeatability of measuring the electrical impedance of the pregnant human cervix: The effect of probe size and applied pressure. Biomedical Engineering Online, 8, Article 10. LINK
-
Gandhi, S. V., Walker, D. C., Brown, B. H., & Anumba, D. O. (2006). Comparison of human uterine cervical electrical impedance measurements derived using two tetrapolar probes of different sizes. Biomedical Engineering Online, 5, Article 62. LINK
-
Gandhi, S. V., Walker, D., Milnes, P., Mukherjee, S., Brown, B. H., & Anumba, D. O. (2006). Electrical impedance spectroscopy of the cervix in non-pregnant and pregnant women. European Journal of Obstetrics & Gynecology and Reproductive Biology, 129(2), 145–149. LINK
-
Meet our team
Leadership Team
Dabriel Choi
CEO
Dr. Gordon Scarth
CTO
Dr. Shaolin Liang
CSO
Sunny Gong
Executive Projects Manager
Dr. Yongjin Choi
Sr. Research Fellow
Advisory Team
Prof. Dilly Anumba
Inventor & Clinical Advisor
Prof. Dharmintra Pasupathy
Clinical Advisor
Dr. Deama Amr
Clinical Advisor
Prof. Youngju Kim
Clinical Advisor:
Nathan McNally
Brand Ambassador
Award-winning
Global Partnership
Together We Save
Contact Us
Head Office
Unit 3D North Point House, North Point Business Park, New Mallow Road, Cork, T23 AT2P, Ireland
© 2025 EveryBaby
THE PROBLEM
Out of every 10 babies born, 1 is preterm.
Every two seconds, a baby is born too soon. Tragically, every 40 seconds, one of these babies loses their life.
Despite medical advancements, global preterm birth rates have remained stagnant over the past decade.
Families of preterm infants face immense emotional and psychological stress, including anxiety and uncertainty about their child’s health.
Source:
-
Comparison of Mental Health and Self-Efficacy of Mothers with Preterm and Term Infants: A Case-Control Study (2019)
-
WHO: Born Too Soon – Decade of Action on Preterm Birth (2023)
More than 1 in 10 babies is born prematurely each year
125 babies die every hour from preterm birth complication worldwide
40% of babies born extremely early (<28 weeks) have chronic lung disease, 25% have visual impairment, and 10% have hearing impairment
Preterm birth rate has been rising in last 30 years